ifosfamide has been researched along with Febrile Neutropenia in 3 studies
Febrile Neutropenia: Fever accompanied by a significant reduction in the number of NEUTROPHILS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This randomised phase II/III trial aimed to determine whether perioperative chemotherapy with gemcitabine plus docetaxel (GD) is non-inferior to the standard Adriamycin plus ifosfamide (AI) in terms of overall survival (OS) in patients with soft tissue sarcoma (STS)." | 9.51 | Perioperative Adriamycin plus ifosfamide vs. gemcitabine plus docetaxel for high-risk soft tissue sarcomas: randomised, phase II/III study JCOG1306. ( Abe, S; Akisue, T; Asanuma, K; Emori, M; Fukuda, H; Furuta, T; Hatano, H; Hiraga, H; Hiraoka, K; Hiruma, T; Iwamoto, Y; Katagiri, H; Kataoka, T; Kawai, A; Kawano, M; Kawashima, H; Machida, R; Matsumoto, Y; Morii, T; Nagano, A; Nakayama, R; Nishida, Y; Okuma, T; Outani, H; Ozaki, T; Suehara, Y; Takenaka, S; Takeyama, M; Tanaka, K; Toguchida, J; Tsukushi, S; Watanuki, M; Yamamoto, T; Yonemoto, T, 2022) |
| "This randomised phase II/III trial aimed to determine whether perioperative chemotherapy with gemcitabine plus docetaxel (GD) is non-inferior to the standard Adriamycin plus ifosfamide (AI) in terms of overall survival (OS) in patients with soft tissue sarcoma (STS)." | 5.51 | Perioperative Adriamycin plus ifosfamide vs. gemcitabine plus docetaxel for high-risk soft tissue sarcomas: randomised, phase II/III study JCOG1306. ( Abe, S; Akisue, T; Asanuma, K; Emori, M; Fukuda, H; Furuta, T; Hatano, H; Hiraga, H; Hiraoka, K; Hiruma, T; Iwamoto, Y; Katagiri, H; Kataoka, T; Kawai, A; Kawano, M; Kawashima, H; Machida, R; Matsumoto, Y; Morii, T; Nagano, A; Nakayama, R; Nishida, Y; Okuma, T; Outani, H; Ozaki, T; Suehara, Y; Takenaka, S; Takeyama, M; Tanaka, K; Toguchida, J; Tsukushi, S; Watanuki, M; Yamamoto, T; Yonemoto, T, 2022) |
| "During the 378 cycles, consisting of 212 for bleomycin, etoposide and cisplatin, and 166 for paclitaxel, ifosfamide and cisplatin, 81 episodes of febrile neutropenia (21." | 3.85 | Identification of risk factors predicting febrile neutropenia in patients with metastatic germ cell tumors receiving cisplatin-based combination chemotherapy. ( Fujisawa, M; Miyake, H; Nishikawa, M, 2017) |
| " The aim of this study was to assess the efficacy and safety of ifosfamide in combination with carboplatin and etoposide (ICE) in previously untreated patients with SCLC." | 1.42 | Efficacy and safety of ifosfamide in combination with carboplatin and etoposide in small cell lung cancer. ( Koo, DH; Lee, HS; Lee, SS; Lee, YG; Lim, SY; Nam, H; Oh, S; Song, JU, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Tanaka, K | 1 |
| Machida, R | 1 |
| Kawai, A | 1 |
| Nakayama, R | 1 |
| Tsukushi, S | 1 |
| Asanuma, K | 1 |
| Matsumoto, Y | 1 |
| Hiraga, H | 1 |
| Hiraoka, K | 1 |
| Watanuki, M | 1 |
| Yonemoto, T | 1 |
| Abe, S | 1 |
| Katagiri, H | 1 |
| Nishida, Y | 1 |
| Nagano, A | 1 |
| Suehara, Y | 1 |
| Kawashima, H | 1 |
| Kawano, M | 1 |
| Morii, T | 1 |
| Hatano, H | 1 |
| Toguchida, J | 1 |
| Okuma, T | 1 |
| Takeyama, M | 1 |
| Takenaka, S | 1 |
| Akisue, T | 1 |
| Furuta, T | 1 |
| Emori, M | 1 |
| Hiruma, T | 1 |
| Outani, H | 1 |
| Yamamoto, T | 1 |
| Kataoka, T | 1 |
| Fukuda, H | 1 |
| Ozaki, T | 1 |
| Iwamoto, Y | 1 |
| Nishikawa, M | 1 |
| Miyake, H | 1 |
| Fujisawa, M | 1 |
| Lee, HS | 1 |
| Lee, YG | 1 |
| Koo, DH | 1 |
| Oh, S | 1 |
| Nam, H | 1 |
| Song, JU | 1 |
| Lim, SY | 2 |
| Lee, SS | 1 |
1 trial available for ifosfamide and Febrile Neutropenia
| Article | Year |
|---|---|
Perioperative Adriamycin plus ifosfamide vs. gemcitabine plus docetaxel for high-risk soft tissue sarcomas: randomised, phase II/III study JCOG1306.
Topics: Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Docetaxel; Doxorubicin; Febrile Neutr | 2022 |
2 other studies available for ifosfamide and Febrile Neutropenia
| Article | Year |
|---|---|
Identification of risk factors predicting febrile neutropenia in patients with metastatic germ cell tumors receiving cisplatin-based combination chemotherapy.
Topics: Androstenes; Antineoplastic Combined Chemotherapy Protocols; Baltimore; Benzamides; Cisplatin; Febri | 2017 |
Efficacy and safety of ifosfamide in combination with carboplatin and etoposide in small cell lung cancer.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Sma | 2015 |